NCT06230393
终止
不适用
An Extension Trial to Evaluate the Long Term Safety and Effectiveness of the STREAMLINE® SURGICAL SYSTEM in Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Open Angle Glaucoma
- 发起方
- New World Medical, Inc.
- 入组人数
- 17
- 试验地点
- 1
- 主要终点
- Change in IOP
- 状态
- 终止
- 最后更新
- 上个月
概览
简要总结
The purpose of this study is to evaluate long term safety and effectiveness of the STREAMLINE® SURGICAL SYSTEM
详细描述
A Retrospective, nonrandomized, open-label study to evaluate the long term safety and IOP-lowering effectiveness of STREAMLINE® SURGICAL SYSTEM in patients with open-angle glaucoma who participated in the DF6-CL-20-01 protocol.
研究者
入排标准
入选标准
- •participated in the DF6-CL-20-01 trial.
排除标准
- •lost to follow up in the DF6-CL-20-01 trial
结局指标
主要结局
Change in IOP
时间窗: 24months; 36 months; 48months, 60 months
From Screening to annual endpoints
次要结局
- Number of IOP lowering medications(24months; 36 months; 48months, 60 months)
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopneaObstructive Sleep Apnea HypopneaObstructive Sleep ApneaOSAHNCT00849043Ventus Medical, Inc.65
Enrolling By Invitation
2 期
Long-term Follow-Up Study of RGX-314 and Fellow Eye SubstudyNeovascular Age-related Macular DegenerationWet Macular DegenerationNCT03999801AbbVie865
Unknown
不适用
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMDNeovascular Age-Related Macular Degeneration (nAMD)Gene TherapyAMDWet AMDwAMDnAMDNCT05210803AbbVie115
Enrolling By Invitation
不适用
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic RetinopathyDiabetic Retinopathy, DRNCT05296447AbbVie100
已完成
3 期
Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)Chronic Obstructive Pulmonary DiseaseNCT00970268AstraZeneca291